India  

Explained: India announces Covid vaccination launch date; who's first in line?

Video Credit: HT Digital Content - Duration: 01:34s - Published
Explained: India announces Covid vaccination launch date; who's first in line?

Explained: India announces Covid vaccination launch date; who's first in line?

The Government of India announced the launch date of its mass immunisation programme against Covid-19.

The vaccinations will begin on January 16, 2021.

On January 3, India's drug regulator DCGI had cleared 2 vaccines - Covaxin and Covishield - for emergency use.

Covaxin, made by Bharat Biotech, will be used under clinical trial conditions, as per the government.

Covishield was developed by Oxford university and pharma major AstraZeneca, and is being made in India by Serum Institute of India (SII).

Around 30 crore people are being targeted for vaccination in phase 1.

These include healthcare staff, frontline workers like police, those aged above 50, and those aged below 50 but with co-morbidities.

Watch the full video for more.


You Might Like


💡 newsR Knowledge: Other News Mentions

Government of India Government of India Legislative, executive and judiciary powers of India

India to work closely with UK for early extradition of Nirav Modi: MEA [Video]

India to work closely with UK for early extradition of Nirav Modi: MEA

MEA Spokesperson Anurag Srivastava on February 25 informed that Government of India in liaison with the authorities of United Kingdom for early extradition of fugitive economic offender Nirav Modi who has been ordered by a local court to be extradited to India. West Minister magistrate court in London had pronounced that Nirav Modi be extradited to stand trial in India. Anurag Srivastava said, "They have dismissed his mental health concerns and the judge has observed that Nirav Modi has conspired to destroy evidence and intimidate witnesses. Now since the magistrate court has recommended Nirav Modi's extradition to the UK Home Secretary." The Indian businessman had fled the country in early 2018 as the news of Punjab National Bank scam worth around Rs 14,000 crore surfaced.

Credit: ANI    Duration: 01:01Published
China's strategy won't work with India | Army Chief Gen Naravane | Oneindia News [Video]

China's strategy won't work with India | Army Chief Gen Naravane | Oneindia News

PM Modi said at an event in Puducherry today that the Government of India has made several efforts to improve connectivity to give farmers a better market for produce; A Delhi court on Thursday granted protection from arrest to Shantanu Muluk in the toolkit case till March 9; As many as 229 covid-19 cases have emerged from a single hostel in a school in Maharashtra's Washim district. All this and more news at 2 PM. #ModiInPuducherry #SouthChinaSea #CovidSpike

Credit: Oneindia    Duration: 02:41Published
GoI's focus on 'Ease of Doing Business' to encourage foreign OEMs: Rajnath Singh [Video]

GoI's focus on 'Ease of Doing Business' to encourage foreign OEMs: Rajnath Singh

Defence Minister Rajnath Singh on February 22 said Government of India's clear focus is on 'Ease of Doing Business' in order to encourage foreign OEMs to set up manufacturing units in India. "GoI has brought many reforms in last 6 years. There is a clear focus of the government on 'Ease of Doing Business' to encourage foreign OEMs, to set up manufacturing units in India, develop joint ventures and promote private participation in defence sector," said Defence Minister.

Credit: ANI    Duration: 01:02Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Wax celebrities join diners at NYC restaurant for COVID-safe experience [Video]

Wax celebrities join diners at NYC restaurant for COVID-safe experience

The Hollywood elite in wax form filled out seats at the NYC eatery.

Credit: euronews (in English)    Duration: 00:50Published
Bill Hader remembers music producer Hal Willner [Video]

Bill Hader remembers music producer Hal Willner

’SNL could be such a hard place,’ says Bill Hader, but producer Hal Willner, who died April 7, 2020 of COVID complications, ‘constantly reminded me that it should be fun, and how lucky we were that we got to do this for a living.’

Credit: Bleacher Report AOL    Duration: 01:35Published
Tamil Nadu's salt workers protecting India from COVID: Rahul Gandhi [Video]

Tamil Nadu's salt workers protecting India from COVID: Rahul Gandhi

Ahead of the Assembly polls in Tamil Nadu, Congress leader Rahul Gandhi is effectively campaigning in several cities of the state. During his rally in Tirunelveli on February 27, Rahul Gandhi said, "Today a worker at salt pan told me "brother the salt we are collecting is helping fight coronavirus, work I am doing here, collecting salt, goes into medicine used to treat corona. I am not only collecting salt but protecting country from corona". That is beauty of your state."

Credit: ANI    Duration: 01:47Published

Registration for next round of Covid vaccination likely to start Monday

“Co-Win as well as other IT applications and platforms will go live from Monday morning around 10 am. People will be required to just fill in a few details and..
IndiaTimes

Drugs Controller General of India

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human..
IndiaTimes
‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval [Video]

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the indigenously developed Covaxin, which is in the third phase of trials and has been cleared for restricted emergency use by the Drugs Controller General of India. ‘Government should act in a manner whereby there's complete confidence in people. You can't use rollout as phase 3 trial, Indians are not guinea pigs,’ Manish Tewari said. The former minister’s remarks come after government hinted that people will not be allowed to choose from the two vaccines recently approved. The first phase of coronavirus vaccination is all set to begin on 16th January, 2021. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 01:40Published

BBV152 BBV152 Vaccine against COVID-19

They thought they got the Covid-19 vaccine. They were part of a trial instead [Video]

They thought they got the Covid-19 vaccine. They were part of a trial instead

More than a dozen slum residents in Bhopal, India, say they thought they were being vaccinated for Covid-19. They say they later discovered from local activists that some of them hadn’t been given an approved vaccine and had unwittingly taken part in a Phase 3 clinical trial for India’s homegrown vaccine, Covaxin. CNN’s Vedika Sud reports.

Credit: Bleacher Report AOL    Duration: 03:42Published

Brazil to buy 20 million Covid-19 vaccines from India's Bharat Biotech

Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery..
IndiaTimes
"Covaxin is successful in tackling UK strain," informs ICMR [Video]

"Covaxin is successful in tackling UK strain," informs ICMR

Indian Council of Medical Research DG, Balram Bhargava announced that the Covaxin is successful in tackling UK strain. He further informed that UK variant strain is now present in 70 countries and 164 cases have been identified in India. "UK variant strain is now present in 70 countries and we've identified 164 cases of it in India. We were able to find the first case of the UK variant on 22nd-23rd December. In a week's time, we were able to collect blood from these patients and culture the strain. We found that the neutralisation of UK strain was equivalent to Indian strains circulating in India. It's a very reassuring news that UK variant can be tackled by this vaccine," informed ICMR DG during a press briefing on January 28.

Credit: ANI    Duration: 01:55Published

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Vaccine against COVID-19

Guatemala President thanks India for donating 2 lakh vaccine doses [Video]

Guatemala President thanks India for donating 2 lakh vaccine doses

Guatemala President Alejandro Giammattei thanked Prime Minister Narendra Modi and External Affairs Minister S Jaishankar for donating 2,00,000 doses of Covishield vaccines. President Alejandro Giammattei said, "I would like to start by thanking Prime Minister of India, Mr. Narendra Modi, and External Affairs Minister S Jaishankar for accepting our call for assistance in supply of Covishield vaccines manufactured in India under licensing of Astra Zeneca. It has been a grand surprise for us to know that India rather than selling the vaccines to us, it has immediately donated to us 200 thousand doses that will help to immunise frontline, health workers."

Credit: ANIPublished

President Ghani lauds PM Modi as Afghanistan begins COVID-19 vaccination using India-made vaccine

India had gifted 500,000 doses of COVISHIELD vaccines earlier this month to Afghanistan.
DNA
Sri Lanka cancels Pakistan PM Imran Khan's speech in the paliament| Oneindia News [Video]

Sri Lanka cancels Pakistan PM Imran Khan's speech in the paliament| Oneindia News

Sri Lanka has cancelled a scheduled speech of Pakistan's prime minister, Imran Khan in parliament. This is being seen as a move to avoid confrontation with New Delhi. India had recently gifted 5 lakh doses of Covishield to Sri Lanka. In recent month there have been anti-Muslim sentiments in Sri Lanka as the Buddhist people have been protesting against animal sacrifices in Mosques. #ImranKhan #PakistanPM #SriLanka

Credit: Oneindia    Duration: 01:03Published
Nepal to begin inoculation drive for elderlies from next month [Video]

Nepal to begin inoculation drive for elderlies from next month

As the vaccination drive has already been kicked off in the Himalayan nation, the inoculation drive for elderly and most vulnerable age groups will commence from next month. Nepal has received the first batch of one million COVISHIELD Vaccine developed by Serum Institute of India on Sunday via Air India flight. The vaccines would be used to inoculate people above 60 years of age, which is 8.73 per cent of Nepal's population, in the vaccination drive that will begin on March 7. According to the Ministry of Health and Population, there are 2,652,258 elderly people above 60 years in the country. On January 21st 2021, Nepal had received a total of One Million COVISHIELD Vaccine from India under grant assistance.

Credit: ANI    Duration: 01:44Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).

Credit: ANI    Duration: 01:28Published
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

AstraZeneca British-Swedish pharmaceutical company

Canada approves AstraZeneca's COVID-19 shot [Video]

Canada approves AstraZeneca's COVID-19 shot

Canada on Friday approved AstraZeneca's COVID-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive next week.

Credit: Reuters Studio    Duration: 01:30Published
Angela Merkel did not "refuse" the AstraZeneca vaccine, despite this being reported [Video]

Angela Merkel did not "refuse" the AstraZeneca vaccine, despite this being reported

Newspapers claimed the German Chancellor refused to have the vaccine. However, she wasn't offered it because she is above the age threshold.

Credit: euronews (in English)    Duration: 02:07Published

University of Oxford University of Oxford Collegiate research university in Oxford, England

One dose Pfizer coronavirus vaccine wards off asymptomatic transmission [Video]

One dose Pfizer coronavirus vaccine wards off asymptomatic transmission

A single dose of the Pfizer-BioNTech coronavirus vaccine reduces the risk of asymptomatic infections, helping to stem transmission, research suggests.The UK has approved three coronavirus jabs – Pfizer-BioNTech, AstraZeneca-University of Oxford and Moderna – after studies demonstrated they significantly ward off severe disease.With not everyone able to be immunised, or producing a strong immune response as a result of their vaccination, questions lingered as to whether the jabs prevented the infection itself.Asymptomatic infections are particularly important amid the pandemic, given these individuals do not know to isolate and may unwittingly transmit the coronavirus even when they speak.To learn more, medics from the Cambridge University Hospitals NHS Foundation Trust (CUH) swabbed the site's vaccinated and unvaccinated healthcare workers over two weeks.Results suggest the risk of an asymptomatic infection decreases by four times more than 12 days after a worker received the Pfizer-BioNTech jab.

Credit: Yahoo News    Duration: 00:53Published

Oxford jab more effective when doses are delivered three months apart - study

The Oxford vaccine is more effective when doses are delivered three months apart rather than six weeks, a new study has confirmed.
Sky News
Oxford-AstraZeneca vaccine tested on children [Video]

Oxford-AstraZeneca vaccine tested on children

Trials have begun to determine the strength of immunity of the Oxford-AstraZeneca Covid vaccine on children aged between six and 17. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:58Published
'Great confidence' in AstraZeneca, despite variants: Johnson [Video]

'Great confidence' in AstraZeneca, despite variants: Johnson

British Prime Minister Boris Johnson in an interview with CBS on Sunday said he has "great confidence" in the AstraZeneca and Oxford University COVID-19 vaccine, despite being shown to be less effective against certain variants of the novel coronavirus.

Credit: Reuters Studio    Duration: 01:01Published

Related videos from verified sources

COVID: Delhiites refuse to follow precautions, cases surge [Video]

COVID: Delhiites refuse to follow precautions, cases surge

After a brief decline, COVID cases once again on uphill in the country. One of the reasons of the spike is carelessness. COVID-19 precautionary measures are highly neglected at the public places...

Credit: ANI     Duration: 03:37Published
India reports 16,488 new COVID cases [Video]

India reports 16,488 new COVID cases

On February 27, total COVID-19 tally of India reached to 1,10,79,979. The country reported 16,488 new COVID-19 cases in last 24 hours and active cases stand at 1,59,590. With new 12,771 discharges,..

Credit: ANI     Duration: 01:04Published
Indonesia kicks off mass COVID-19 vaccinations for journalists [Video]

Indonesia kicks off mass COVID-19 vaccinations for journalists

Indonesia kicked off its mass COVID-19 vaccination of journalists on February 25. Footage from inside the Gelora Bung Karno Stadium in Jakarta shows 5,500 journalists getting their COVID-19 vaccine.

Credit: Newsflare STUDIO     Duration: 02:02Published